Effects of Eluxadoline (Viberzi®) 100 mg Twice Daily on Diarrhea-Associated Fecal Incontinence

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2019

Primary Completion Date

September 30, 2019

Study Completion Date

March 31, 2020

Conditions
Fecal IncontinenceAccidental Bowel LeakageAnal IncontinenceDiarrheaUrge Incontinence
Interventions
DRUG

Eluxadoline 100 mg

100 mg capsule-shaped tablet by mouth taken twice per day

OTHER

Placebo

Matching capsule-shaped placebo tablets taken by mouth twice per day

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

University of North Carolina, Chapel Hill

OTHER